HIGHBRIDGE CAPITAL MANAGEMENT LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 67 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2022$11,035,000
+6.9%
1,092,529
+6.1%
0.16%
-34.0%
Q2 2022$10,323,000
-0.2%
1,029,262
-0.5%
0.24%
-2.5%
Q1 2022$10,340,000
+0.5%
1,033,950
-0.4%
0.24%
+7.1%
Q4 2021$10,285,0001,037,7940.22%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q3 2022
NameSharesValueWeighting ↓
Sea Otter Advisors LLC 124,500$1,256,0002.63%
Lynwood Capital Management Inc. 39,615$400,0000.44%
METEORA CAPITAL, LLC 164,721$1,662,0000.42%
Sage Rock Capital Management LP 183,998$1,857,0000.41%
HGC Investment Management Inc. 500,000$5,045,0000.34%
MMCAP International Inc. SPC 370,000$3,733,0000.30%
Bulldog Investors, LLP 97,364$982,0000.29%
Atalaya Capital Management LP 200,000$2,020,0000.27%
Context Capital Management, LLC 400,000$4,036,0000.27%
PERISCOPE CAPITAL INC. 752,259$7,590,0000.22%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders